Kejing Tang Selected Research

Kejing Tang Research Topics

Disease

18	Leukemia 03/2022 - 09/2009
15	Neoplasms (Cancer) 03/2022 - 07/2009
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2022 - 09/2009
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2022 - 08/2012
4	Adenocarcinoma of Lung 08/2021 - 01/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2021 - 01/2019
2	Lung Neoplasms (Lung Cancer) 08/2021 - 02/2020
2	Breast Neoplasms (Breast Cancer) 01/2021 - 08/2012
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2019 - 01/2010
2	Wilms Tumor (Wilm's Tumor) 09/2017 - 12/2014
1	Myositis (Idiopathic Inflammatory Myopathies) 10/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2022
1	Residual Neoplasm 03/2022
1	COVID-19 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Cognitive Dysfunction 01/2020
1	Carcinogenesis 01/2020
1	B-Cell Leukemia (Leukemia, B Cell) 01/2019
1	Lymphoid Leukemia 01/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2018
1	Iron Deficiencies 11/2015
1	Acute Promyelocytic Leukemia 08/2014
1	Myeloid Leukemia (Leukemia, Myelocytic) 10/2013
1	Fibrosis (Cirrhosis) 01/2010

Drug/Important Bio-Agent (IBA)

11	Chimeric Antigen ReceptorsIBA 03/2022 - 03/2016
5	Biological ProductsIBA 01/2021 - 08/2012
4	CytokinesIBA 01/2022 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 11/2021 - 09/2015
3	Tyrosine Kinase InhibitorsIBA 08/2021 - 01/2019
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2021
2	osimertinibIBA 08/2021 - 01/2019
2	Interleukin-2 (IL2)IBA 01/2021 - 03/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 09/2015
2	LigandsIBA 03/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
2	CateninsIBA 01/2019 - 12/2014
2	AntigensIBA 01/2019 - 03/2016
2	GTP Phosphohydrolases (GTPases)IBA 01/2016 - 10/2013
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2022
1	ErbB Receptors (EGF Receptor)IBA 08/2021
1	cabozantinibIBA 08/2021
1	Anaplastic Lymphoma KinaseIBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	Interleukin-10 ReceptorsIBA 01/2021
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	polyethylene glycol-poly(lactide-co-glycolide)IBA 02/2020
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2020
1	SirtuinsIBA 01/2020
1	Superoxides (Superoxide)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	CollagenIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Gefitinib (Iressa)FDA Link 01/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	Therapeutic UsesIBA 01/2019
1	telomerase RNA (bTR)IBA 05/2018
1	Cyclin-Dependent Kinase Inhibitor p16IBA 04/2018
1	Co-Repressor ProteinsIBA 04/2018
1	Cytokine Receptors (Cytokine Receptor)IBA 04/2018
1	Histone Deacetylase InhibitorsIBA 01/2018
1	Serine Proteases (Serine Protease)IBA 09/2017
1	Single-Chain AntibodiesIBA 03/2016
1	IronIBA 11/2015
1	RetinoidsIBA 08/2014
1	AcidsIBA 08/2014
1	Cadherins (E-Cadherin)IBA 05/2014
1	Imatinib Mesylate (Gleevec)FDA Link 04/2014
1	Etoposide (VP 16)FDA LinkGeneric 08/2012
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 08/2012
1	Arginine (L-Arginine)FDA Link 08/2012
1	OligonucleotidesIBA 02/2011
1	Coloring Agents (Dyes)IBA 01/2010
1	SteroidsIBA 01/2010
1	Small Interfering RNA (siRNA)IBA 09/2009
1	rac1 GTP-Binding ProteinIBA 09/2009
1	MidkineIBA 07/2009
1	Heparin (Liquaemin)FDA LinkGeneric 07/2009
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2009

Therapy/Procedure

8	Therapeutics 03/2022 - 05/2018
4	Drug Therapy (Chemotherapy) 01/2020 - 10/2013
2	Immunotherapy 03/2022 - 01/2019
2	Transplantation 11/2018 - 05/2014
1	Lung Transplantation 05/2018
1	Ligation 04/2018
1	Pleurodesis 01/2010